Tag: Press Release

Comprehensive Genomic Testing Reveals Treatment Targets in 90% of Advanced Solid Tumors

July 29, 2025

“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced solid tumors.” BUFFALO, NY -… read more

Oncotarget

Blood Filtration Stabilizes Advanced Pancreatic Cancer: A Case Report

July 24, 2025

“Therapeutic modalities that explore CTC removal via blood filtration may potentially have promising clinical benefits.” BUFFALO, NY - July 24, 2025 – A new case report was published in Volume… read more

Oncotarget

Cholesterol-Lowering Drugs Show Promise Against Colorectal Cancer

July 22, 2025

“Our findings provide direct evidence that statins selectively modulate key components of the Wnt/β-catenin signaling pathway, a major driver of adenoma formation, including members of the special AT-rich sequence-binding (SATB)… read more

Oncotarget

microRNAs Emerge as Biomarkers and Diagnostic Tools in Soft Tissue Sarcoma

July 18, 2025

“[...] miRNAs are pivotal in regulating gene expression in STS and have been recognized as crucial biomarkers for the diagnosis, prognosis, and therapeutic decision-making in patients.” BUFFALO, NY - July… read more

Oncotarget

New Antibody Selectively Targets Immune Cells That Suppress Anti-Tumor Responses

July 16, 2025

“Taken together, our studies suggest that 2B010 represents an anti-CD25 mAb with unique properties in that it deleted Treg from an inflammatory environment (GVHD) as well as from the TME.”… read more

Oncotarget

Prostate Cancer Cells Survive Treatment by Storing Fat in Low Oxygen Conditions

July 14, 2025

“[...] manipulating LD dynamics represents a promising strategy to overcome hypoxia-induced resistance to ferroptosis and improve the success of PCa treatment.” BUFFALO, NY - July 14, 2025 – A new… read more

Oncotarget

EGFR-Targeted Therapy Resistance in Breast and Head & Neck Cancers

July 9, 2025

“By synthesizing current insights on both RTK and non-RTK mediated resistance against anti-EGFR therapies, this review aims to guide future research and improve therapeutic strategies for these cancers.” BUFFALO, NY… read more